---

$9.08

-0.1700 ( -1.84% ) 834.0K

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-01-12	Buy	3410713.00	PERCEPTIVE ADVISORS LLC
2024-01-12	Buy	904160.00	RA CAPITAL MANAGEMENT, L.P.
2024-01-12	Sale	-904160.00	Koppel Adam
2024-01-12	Sale	-904160.00	Bain Capital Life Sciences Investors, LLC
2024-01-11	Sale	-11250.00	Tan Kevin
2024-01-05	Sale	-15570.00	SMITH IAN F
2024-01-05	Sale	-2993.00	Ganot Ilan
2023-12-05	Sale	-7238.00	Herzich Paul
2023-12-05	Sale	-11862.00	Hanrahan Jessie
2023-12-05	Sale	-13051.00	Howton David T